2022-502492-32-00
CTIS ↗
0.9% Sodium Chloride Injection, mRNA-3705
Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency
biotech · Propionic Acidemia · Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency
SOM Biotech
Moderna Biotech Spain
SOM Biotech trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Barcelona, ES HQ
2009 Founded
14 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Barcelona, ES
- Founded
- 2009
- Employees
- 14
- Programs
- 10
- Drugs
- 27
- Patents
- 0
SOM Biotech clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to SOM Biotech programs — each row shows trial ID, program name, phase, status, and indication.
SOM Biotech trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for SOM Biotech.
-
mRNA-1010-P304 — Phase 3
Clinical update -
DAN-COVID — Approved
Clinical update -
mRNA1647-P301 — Phase 3
Clinical update -
mRNA-3927-P101 — Phase 2
Clinical update -
mRNA-3745-P102 — Phase 2
Clinical update -
mRNA 3210-P101 — Phase 2
Clinical update -
SODIUM CHLORIDE SOLUTION 0.9%, mRNA-1345 — Phase 2
Clinical update -
0.9% Sodium Chloride Injection, mRNA-3705 — Phase 2
Clinical update